Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GnRH Antagonist vs Agonist for Endometrium Preparation in Oocyte Recipients
NCT00633347Phase 4Completed
- Sponsor
- IVI
- Start
- Jan 2007
- Primary completion
- Oct 2009
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of cetrorelix in infertility (2 arms), sponsored by IVI. Primary endpoint: Clinical Pregnancy Rate at 1 month. Started Jan 2007; status: completed.
02
Drugs
cetrorelix
03
Conditions
infertility
Beyond the preview
Go deeper on NCT00633347.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00633347.